FDA cuts stir buy­er’s re­morse for some bio­phar­ma lead­ers, once ex­cit­ed by Trump

Last month
Pharma
Cell/Gene Tx

FTC's fight against PBMs is paused

Last month
Pharma
Law

Day af­ter mass FDA fir­ings, new com­mis­sion­er ad­dress­es re­main­ing staff, fo­cus­ing on 'MA­HA' vi­sion

Last month
FDA+

Eli Lil­ly adds obe­si­ty start­up known­well to its di­rect-to-con­sumer ser­vice

Last month
Startups
Pharma

Q&A: John Crow­ley warns biotech is 'dan­ger­ous­ly close' to break­ing, as tar­iff threat, mar­kets bat­ter in­dus­try

Last month
People
Pharma

Tang Cap­i­tal's Con­cen­tra nabs a win, mak­ing a deal to buy Al­lakos

Last month
Deals

Roche says Ocre­vus failed Phase 3 study; Sanofi li­cens­es au­toim­mune as­set from Nurix

Last month
News Briefing

Ex­clu­sive: Mikael Dol­sten shares his post-Pfiz­er plans, in­clud­ing ad­vis­ing an AI uni­corn with phar­ma dreams

Last month
People
AI

At­se­na gets Bain's sup­port in $150M Se­ries C to thwart blind­ness with gene ther­a­py

Last month
Financing
Startups

Edge­wise's heart drug shows promise in Phase 2 tri­al

Last month
R&D

Arie Bellde­grun nabs two lead­ers for Vi­da Ven­tures amid plans for fourth fund

Last month
People

New CD­MO emerges, ac­quires cell and gene man­u­fac­tur­er Land­mark Bio

Last month
Deals
Cell/Gene Tx

Judge or­ders HHS, oth­er agen­cies to 'un­do' pro­ba­tion­ary work­er fir­ings

Last month
Pharma
FDA+

‘It’ll be a chal­lenge’: BIO chief Crow­ley ad­dress­es seis­mic FDA over­haul

Last month
People
Pharma

Eli Lil­ly sues large com­pound­ing phar­ma­cies Em­pow­er, Strive over tirzepatide prod­ucts

Last month
Pharma
Health Tech

RFK Jr. has long crit­i­cized drug ads. He just slashed the FDA of­fice that reg­u­lates them

Last month
Pharma
FDA+

Eu­ro­pean drug reg­u­la­tor seeks to ‘stream­line’ biosim­i­lar ap­proval process

Last month
Pharma
FDA+

Zus Health CEO Jonathan Bush on the fu­ture of health records

Last month
Health Tech

Ax­some re­ports Phase 3 de­pres­sion fail for Sunosi

Last month
R&D

Com­pass Ther­a­peu­tics touts tri­al suc­cess in bil­iary tract can­cer, but more da­ta are need­ed

Last month
R&D

Gubra’s Ab­b­Vie-part­nered amylin looks com­pet­i­tive with Zealand’s in ear­ly tri­al

Last month
R&D

Q&A: Demis Has­s­abis talks 'tur­bocharg­ing' Iso­mor­phic with $600M, ex­pand­ing in­to an­ti­bod­ies and the US

Last month
People
AI

Praz­er Ther­a­peu­tics rais­es $20M; Caris­ma lets go of most staff

Last month
News Briefing

Fir­ings sweep across FDA as for­mer lead­ers lament the gut­ting of drug agency

Last month
People
FDA+
First page Previous page 10111213141516 Next page Last page
A service from the Financial Times